JPWO2022051245A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022051245A5
JPWO2022051245A5 JP2023513939A JP2023513939A JPWO2022051245A5 JP WO2022051245 A5 JPWO2022051245 A5 JP WO2022051245A5 JP 2023513939 A JP2023513939 A JP 2023513939A JP 2023513939 A JP2023513939 A JP 2023513939A JP WO2022051245 A5 JPWO2022051245 A5 JP WO2022051245A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
treatment
responsive
subjects
classifier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023513939A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023538963A5 (https=
JP2023538963A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/048346 external-priority patent/WO2022051245A2/en
Publication of JP2023538963A publication Critical patent/JP2023538963A/ja
Publication of JPWO2022051245A5 publication Critical patent/JPWO2022051245A5/ja
Publication of JP2023538963A5 publication Critical patent/JP2023538963A5/ja
Pending legal-status Critical Current

Links

JP2023513939A 2020-09-01 2021-08-31 抗tnf治療に対する応答を予測するための方法およびシステム Pending JP2023538963A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063073336P 2020-09-01 2020-09-01
US63/073,336 2020-09-01
PCT/US2021/048346 WO2022051245A2 (en) 2020-09-01 2021-08-31 Methods and systems for predicting response to anti-tnf therapies

Publications (3)

Publication Number Publication Date
JP2023538963A JP2023538963A (ja) 2023-09-12
JPWO2022051245A5 true JPWO2022051245A5 (https=) 2024-08-26
JP2023538963A5 JP2023538963A5 (https=) 2024-08-26

Family

ID=80492102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023513939A Pending JP2023538963A (ja) 2020-09-01 2021-08-31 抗tnf治療に対する応答を予測するための方法およびシステム

Country Status (11)

Country Link
US (1) US20230282367A1 (https=)
EP (1) EP4208256A4 (https=)
JP (1) JP2023538963A (https=)
KR (1) KR20240018404A (https=)
CN (1) CN117615780A (https=)
AU (1) AU2021336781A1 (https=)
CA (1) CA3191195A1 (https=)
GB (1) GB2616129A (https=)
IL (1) IL300978A (https=)
MX (1) MX2023002446A (https=)
WO (1) WO2022051245A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019178546A1 (en) 2018-03-16 2019-09-19 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
GB2603294A (en) 2019-06-27 2022-08-03 Scipher Medicine Corp Developing classifiers for stratifying patients
WO2023150731A2 (en) * 2022-02-04 2023-08-10 Scipher Medicine Corporation Systems and methods for predicting response to anti-tnf therapies
CN120015309B (zh) * 2025-01-14 2025-12-12 中国人民解放军军事科学院军事医学研究院 用于急性高原反应(ams)易感性分群的装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2679996A1 (en) * 2007-05-31 2014-01-01 AbbVie Inc. Biomarkers predictive of the responsiveness to TNF-alfa inhibitors in autoimmune disorders
JP5719591B2 (ja) * 2007-06-08 2015-05-20 バイオジェン アイデック エムエー インコーポレイティドBiogen Idec Inc. 抗tnf応答性または非応答性を予測するためのバイオマーカー
CN102171365B (zh) * 2008-08-25 2014-01-29 森托科尔奥索生物科技公司 用于溃疡性结肠炎和相关疾病的抗tnf治疗的生物标记物
KR20220065091A (ko) * 2014-03-27 2022-05-19 제넨테크, 인크. 염증성 장 질환의 진단 및 치료 방법
EP3654993A4 (en) * 2017-07-17 2021-08-25 The Broad Institute, Inc. CELL ATLAS OF HEALTHY HUMAN COLUMN AND HUMAN COLUMN WITH COLITIS ULCEROSA
WO2019178546A1 (en) * 2018-03-16 2019-09-19 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
EA202191354A1 (ru) * 2018-11-15 2021-08-11 Янссен Байотек, Инк. Способы и композиции для прогнозирования ответа на терапию воспалительного заболевания кишечника
GB2603294A (en) * 2019-06-27 2022-08-03 Scipher Medicine Corp Developing classifiers for stratifying patients

Similar Documents

Publication Publication Date Title
JP7297015B2 (ja) エピジェネティックな染色体相互作用
JP2021518432A5 (https=)
GB2603294A (en) Developing classifiers for stratifying patients
EP2769321B1 (en) Methods for improving inflammatory bowel disease diagnosis
GB2616129A (en) Methods and systems for predicting response to anti-TNF therapies
US20160002732A1 (en) Molecular diagnostic test for cancer
CN113755596B (zh) 一种检测喉鳞癌放疗敏感性相关基因atm和atr基因突变的试剂盒及其应用
Dix et al. Biomarker-based classification of bacterial and fungal whole-blood infections in a genome-wide expression study
RU2737449C1 (ru) Система для предсказания прогноза и пользы от вспомогательной химиотерапии для больных раком желудка ii и iii стадии
Burel et al. Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease
Schäffler et al. Mutations in the NOD2 gene are associated with a specific phenotype and lower anti‐tumor necrosis factor trough levels in Crohn's disease
WO2016050111A1 (en) Biomarkers for rheumatoid arthritis and usage thereof
GB2622147A (en) Methods of classifying and treating patients
JPWO2020264426A5 (https=)
JPWO2022051245A5 (https=)
JPWO2019178546A5 (https=)
US20170145501A1 (en) Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response
CN112481380B (zh) 一种评估晚期膀胱癌抗肿瘤免疫治疗反应性和预后生存的标志物及其应用
Kozin et al. Global transcriptome profiling in peripheral blood mononuclear cells identifies dysregulation of immune processes in individuals with radiologically isolated syndrome
CN119242791A (zh) 一种用于诊断急性细菌和病毒感染的宿主基因组合及其应用
EP2701579A2 (en) Stratifying patient populations through characterization of disease-driving signaling
US20030194701A1 (en) Diffuse large cell lymphoma diagnosis and outcome prediction by expression analysis
HK40100171A (en) Methods and systems for predicting response to anti-tnf therapies
WO2023061240A1 (zh) 免疫球蛋白A肾病RhoGTPase相关诊断标志物
CN113943806A (zh) 预测肺腺癌患者对免疫疗法敏感性的生物标志物、应用和装置